Tweet - "While the patent for insulin first sold for $1, Big Pharma's insulin price gouging has forced patients with diabetes to ration doses. That's why last year I worked to pass the Affordable Insulin Approvals Now Act, to ensure FDA would not delay lower-cost insulin options."
Social Media
Issues: Health and Health Care
"While the patent for insulin first sold for $1, Big Pharma's insulin price gouging has forced patients with diabetes to ration doses. That's why last year I worked to pass the Affordable Insulin Approvals Now Act, to ensure FDA would not delay lower-cost insulin options."
"Our bipartisan effort can help millions with diabetes afford the insulin they need. Today, a new "generic" insulin - priced at a fraction of the cost - entered the market, to help expand access for patients."
@SenatorDurbin
Source